Freely Filtered 054: EMPA Kidney!
Freely Filtered, a NephJC Podcast
00:00
Dialysis Reduces Progression of Kidney Disease
No significant difference in any of the adverse events. This one and and more patients discontinued the placebo than actually discontinued the drug, which gives you a good side of how well tolerated this drug was. It is there's a benefit in diabetic patients with high cardiovascular risk. And now we show that it's beneficial in patients with chronic kidney disease, with or without diabetes down to a GFR of 20 without albuminuria. But I think these drugs are really powerful in lots of groups, perhaps every group,. Like, like, I said. We have to find that small, tiny slivers of population who cannot get a benefit from flows in.
Transcript
Play full episode
